Assembly Biosciences
ASMB
43 hedge funds and large institutions have $61.9M invested in Assembly Biosciences in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 17 closing their positions.
0% more capital invested
Capital invested by funds: $61.6M → $61.9M (+$307K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 46 → 43 (-3)
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$4.62M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
+$1.43M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$1.23M |
| 4 |
Millennium Management
New York
|
+$499K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$494K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$8.58M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.87M |
| 3 |
State Street
Boston,
Massachusetts
|
-$799K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$742K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$541K |
ASMB Hedge Fund Activity: Q2 2016 in Review
43 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q2 2016, worth a combined $61.9M — up 0.5% from $61.6M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of ASMB and 14 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 9 added.
The largest buyer was EcoR1 Capital, adding an estimated $4.62M. The largest seller was Visium Asset Management, exiting entirely with an estimated $8.58M sold.
- 43 institutional investors held Assembly Biosciences (ASMB) as of Q2 2016, down from 46 in Q1 2016.
- Funds reported $61.9M of Assembly Biosciences stock for Q2 2016, up 0.5% quarter-over-quarter.
- 14 funds opened new Assembly Biosciences positions in Q2 2016 and 17 closed out, a net change of -3 holders.
- The largest Assembly Biosciences buyer in Q2 2016 was EcoR1 Capital, an estimated $4.62M added.
- The largest Assembly Biosciences seller in Q2 2016 was Visium Asset Management, an estimated $8.58M sold.
Based on aggregated 13F filings for Q2 2016.